In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adults [clinicaltrials:NCT00144352]
In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adults [clinicaltrials:NCT00144352]
Bio2RDF identifier
NCT00144352
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00144352
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
Plasmodium falciparum m ...... unts or who are HIV negative.
brief title [clinicaltrials_vocabulary:brief-title]
In-Vivo Response of P. Falcipa ...... cted and HIV-Uninfected Adults
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
collaborator [clinicaltrials_vocabulary:collaborator]
completion date [clinicaltrials_vocabulary:completion-date]
2004-07-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
The study was conducted ...... ntifolate resistance markers.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2005-09-02T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
Sulfadoxine pyirmethamine
drug efficacy
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2005-09-02T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00144352
official title [clinicaltrials_vocabulary:official-title]
The in-Vivo Response of P. Fal ...... nvolving HIV+ and HIV- Adults.
org study id [clinicaltrials_vocabulary:org-study-id]
CDC-NCID-3537
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
secondary id [clinicaltrials_vocabulary:secondary-id]
UR6/CCU018970-02-2
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2002-09-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2005-09-01T00:00:00Z
identifier
clinicaltrials:NCT00144352
title
In-Vivo Response of P. Falcipa ...... cted and HIV-Uninfected Adults
@en
type
label
In-Vivo Response of P. Falcipa ...... s [clinicaltrials:NCT00144352]
@en